Chemoinformaics analysis of 2-(2-PHENYLETHYL)CHROMONE
| Molecular Weight | 250.297 | nRot | 3 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 18 |
| Exact Molecular Weight | 250.099 | nRing | 3 |
| Solubility: LogS | -4.881 | nHRing | 1 |
| Solubility: LogP | 3.855 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 17 |
| nHA | 2 | APOL | 39.3291 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.711 |
| Synth | 1.813 |
| Natural Product Likeliness | 0.388 |
| NR-PPAR-gamma | 0.029 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.991 |
| Pgp-sub | 0.119 |
| HIA | 0.005 |
| CACO-2 | -4.806 |
| MDCK | 0.0000154 |
| BBB | 0.131 |
| PPB | 0.982553 |
| VDSS | 1.193 |
| FU | 0.0116972 |
| CYP1A2-inh | 0.976 |
| CYP1A2-sub | 0.766 |
| CYP2c19-inh | 0.961 |
| CYP2c19-sub | 0.158 |
| CYP2c9-inh | 0.872 |
| CYP2c9-sub | 0.866 |
| CYP2d6-inh | 0.117 |
| CYP2d6-sub | 0.784 |
| CYP3a4-inh | 0.126 |
| CYP3a4-sub | 0.422 |
| CL | 3.734 |
| T12 | 0.3 |
| hERG | 0.244 |
| Ames | 0.743 |
| ROA | 0.289 |
| SkinSen | 0.738 |
| Carcinogencity | 0.771 |
| EI | 0.97 |
| Respiratory | 0.075 |
| NR-Aromatase | 0.639 |
| Antiviral | Yes |
| Prediction | 0.731826 |